A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema
ObjectiveIn this work, we studied the clinical effect of liposuction followed by lymphovenous anastomosis (LVAs) for the treatment of breast cancer-related lymphedema (BCRL).MethodsWe analyzed 158 patients with unilateral upper limb BCRL who underwent liposuction followed by LVAs 2–4 months later. A...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-03-01
|
| Series: | Frontiers in Surgery |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2023.1065733/full |
| _version_ | 1827989962686988288 |
|---|---|
| author | Kun Chang Song Xia Chen Liang Yuguang Sun Jianfeng Xin Wenbin Shen |
| author_facet | Kun Chang Song Xia Chen Liang Yuguang Sun Jianfeng Xin Wenbin Shen |
| author_sort | Kun Chang |
| collection | DOAJ |
| description | ObjectiveIn this work, we studied the clinical effect of liposuction followed by lymphovenous anastomosis (LVAs) for the treatment of breast cancer-related lymphedema (BCRL).MethodsWe analyzed 158 patients with unilateral upper limb BCRL who underwent liposuction followed by LVAs 2–4 months later. Arm circumferences before and 7 days after the combined treatments were prospectively recorded. Circumferences of different upper extremities were measured before the procedure, 7 days after LVAs, and during the follow-ups. Volumes were calculated with the frustum method. During the follow-ups, the conditions of patients’ treated arms, i.e., the frequency of erysipelas episodes and dependence on compression garments, were recorded.ResultsThe mean circumference difference between two upper limbs decreased significantly from M (P25, P75) of 5.3 (4.1, 6.9) preoperatively to 0.5 (−0.8, 1.0) (P < 0.05) 7 days after treatments, while at follow-up 0.3 (−0.4, 1.0). The mean volume difference decreased significantly from M (P25, P75) of 838.3 (662.4, 1,129.0) preoperatively to 7.8 (−120.3, 151.4) (P < 0.05) 7 days after treatments, while at follow-up 43.7 (−59.4, 161.1). The incidence of erysipelas also significantly decreased (P < 0.05). 6.3% of patients were already independent of compression garments during the past six months or even more.ConclusionLiposuction followed by LVAs is an effective method for the treatment of BCRL. |
| first_indexed | 2024-04-10T00:28:33Z |
| format | Article |
| id | doaj.art-3c40753b71bf42eba2320a0eb8ed3b34 |
| institution | Directory Open Access Journal |
| issn | 2296-875X |
| language | English |
| last_indexed | 2024-04-10T00:28:33Z |
| publishDate | 2023-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Surgery |
| spelling | doaj.art-3c40753b71bf42eba2320a0eb8ed3b342023-03-15T04:53:11ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2023-03-011010.3389/fsurg.2023.10657331065733A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedemaKun ChangSong XiaChen LiangYuguang SunJianfeng XinWenbin ShenObjectiveIn this work, we studied the clinical effect of liposuction followed by lymphovenous anastomosis (LVAs) for the treatment of breast cancer-related lymphedema (BCRL).MethodsWe analyzed 158 patients with unilateral upper limb BCRL who underwent liposuction followed by LVAs 2–4 months later. Arm circumferences before and 7 days after the combined treatments were prospectively recorded. Circumferences of different upper extremities were measured before the procedure, 7 days after LVAs, and during the follow-ups. Volumes were calculated with the frustum method. During the follow-ups, the conditions of patients’ treated arms, i.e., the frequency of erysipelas episodes and dependence on compression garments, were recorded.ResultsThe mean circumference difference between two upper limbs decreased significantly from M (P25, P75) of 5.3 (4.1, 6.9) preoperatively to 0.5 (−0.8, 1.0) (P < 0.05) 7 days after treatments, while at follow-up 0.3 (−0.4, 1.0). The mean volume difference decreased significantly from M (P25, P75) of 838.3 (662.4, 1,129.0) preoperatively to 7.8 (−120.3, 151.4) (P < 0.05) 7 days after treatments, while at follow-up 43.7 (−59.4, 161.1). The incidence of erysipelas also significantly decreased (P < 0.05). 6.3% of patients were already independent of compression garments during the past six months or even more.ConclusionLiposuction followed by LVAs is an effective method for the treatment of BCRL.https://www.frontiersin.org/articles/10.3389/fsurg.2023.1065733/fulllymphedematreatmentliposuctionupper limblymphovenous anastomosisbreast cancer-related lymphedema |
| spellingShingle | Kun Chang Song Xia Chen Liang Yuguang Sun Jianfeng Xin Wenbin Shen A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema Frontiers in Surgery lymphedema treatment liposuction upper limb lymphovenous anastomosis breast cancer-related lymphedema |
| title | A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema |
| title_full | A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema |
| title_fullStr | A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema |
| title_full_unstemmed | A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema |
| title_short | A clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer-related lymphedema |
| title_sort | clinical study of liposuction followed by lymphovenous anastomosis for treatment of breast cancer related lymphedema |
| topic | lymphedema treatment liposuction upper limb lymphovenous anastomosis breast cancer-related lymphedema |
| url | https://www.frontiersin.org/articles/10.3389/fsurg.2023.1065733/full |
| work_keys_str_mv | AT kunchang aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT songxia aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT chenliang aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT yuguangsun aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT jianfengxin aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT wenbinshen aclinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT kunchang clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT songxia clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT chenliang clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT yuguangsun clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT jianfengxin clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema AT wenbinshen clinicalstudyofliposuctionfollowedbylymphovenousanastomosisfortreatmentofbreastcancerrelatedlymphedema |